BioSpace News Archive

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that researchers from the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital presented positive interim data from two ongoing Phase I/II clinical trials evaluating ABO-102 and ABO-101, the Company’s investigational gene therapies for MPS IIIA and MPS IIIB, respectively, at WORLDSymposium™

Platt College Anaheim is now accepting applications for June 30, 2020 program start date

Spectroscopy®, a multimedia platform that promotes the use of spectroscopic instrumentation in applied research, environmental testing, quality control and the life sciences, is proud to announce that editorial advisory board members Howard Mark and Jerome Workman Jr. have been named winners of the 2020 New York Society for Applied Spectroscopy Gold Medal Award.

Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced today the appointment of Edwin C. Hendrick as Chief Commercial Officer.

Anthony Sallustio, DDS, was honored with the Private Practice Prosthodontist Award for the Northeast Region of the American College of Prosthodontists, covering the eastern coast of the United States from Maine to New Jersey.

When the machinery that guides the transition of stem cells to somatic cells doesn’t shut down properly, cells can become cancerous

Inspire Medical Systems, Inc. announced that its management team will be presenting at the 9th Annual SVB Leerink Global Healthcare Conference on February 26, 2020 at the Lotte New York Palace in New York.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter and full year 2019 financial results after the close of trading on Wednesday, February 26, 2020.

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company with expertise in protein misfolding, today reported financial results for the fourth quarter and full year 2019.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019.